Today, On 30th January, The Supreme Court criticized the lower court’s decision to issue summons in a case against a company accused of making poor-quality drugs. The court dismissed the case, saying there was not enough evidence to support the claims. The company was accused of producing substandard medicines, but the Supreme Court found no proof. This ruling raises concerns about how such cases are handled legally.
